(Q33446391)

English

A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Creagan ET

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chang M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Long HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rubin J

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

153-158

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

24-hour infusion of cis-platinum in head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase II

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of 65 measurable epidermoid bronchogenic tumors of known spontaneous doubling time to four different chemotherapeutic regimens — strategic deductions

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of response criteria in advanced lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, adriamycin, and 24-hour infusion of cis-diamminedichloroplatinum (II) in the management of patients with advanced head and neck neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890080305

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.2890080305

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33446391&oldid=1536105498"